Metraipolis › archive › dc_a3d6ff02a96c
Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA — Europe PMC PMID:32109949
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32109949
- DOI
- 10.1371/journal.pone.0229424
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T09:38:09.443Z
- SHA-256 of the archived text
795e52d646921e56bc899074011078cd07803ab57dcef9ff50a2c937003a3418- Stable URL of this page
https://metraipolis.com/documento/dc_a3d6ff02a96c
How to cite
Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA — Europe PMC PMID:32109949 — Europe PMC (en), https://europepmc.org/article/MED/32109949 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a3d6ff02a96c (Metraipolis archive dc_a3d6ff02a96c, sha256 795e52d646921e56bc899074011078cd07803ab57dcef9ff50a2c937003a3418)
BibTeX
@misc{dca3d6ff02a96c,
title = {Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA — Europe PMC PMID:32109949},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32109949},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a3d6ff02a96c; sha256 795e52d646921e56bc899074011078cd07803ab57dcef9ff50a2c937003a3418},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32109949. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Management of Human Immunodeficiency Virus Type 2 (HIV-2) infections present unique challenges due to low viral titers, slow disease progression, and poor response to standard antiviral therapies. The need for a nucleic acid assay to detect and quantify HIV-2 virus has led to the development of a number of molecular-based assays for detection and/or quantification of HIV-2 viral RNA in plasma in order to provide laboratory evidence of HIV-2 infection and viral loads for use in treatment decisions. As HIV-2 is less pathogenic and transmissible than HIV-1 and has resistance to several of the antiretroviral drugs, delay of treatment is common. Cross sero-reactivity between HIV-1 and HIV-2 makes it difficult to distinguish between the two viruses based upon serological tests. As such we developed a quantitative reverse transcription PCR (qRT-PCR) assay targeting the 5' long terminal repeat of HIV-2 for detection and quantification of HIV-2 viral RNA in plasma to identify HIV-2 infection and for use in viral load monitoring. Serial dilutions of cultured HIV-2 virus demonstrated a wide dynamic range (10 to 100,000 copies/ml) with excellent reproducibility (standard deviation from 0.12-0.19), linearity (R2 = 0.9994), and a lower limit of detection at 79 copies/ml (NIH-Z). The assay is highly specific for HIV-2 Groups A and B and exhibits no cross reactivity to HIV-1, HBV or HCV. Precision of the assay was demonstrated for the High (Mean = 6.41; SD = 0.12) and Medium (Mean = 4.46; SD = 0.13) HIV-2 positive controls. Replicate testing of clinical specimens showed good reproducibility above 1,000 copies/ml, with higher variability under 1,000 copies/ml. Analysis of 220 plasma samples from HIV-2 infected West African individuals demonstrated significantly lower viral loads than those observed in HIV-1 infections, consistent with results of previous studies. Slightly more than seven percent of clinical samples (7.3%) demonstrated viral loads above 100,000 copies/ml, while 37.3% of samples were undetectable. The high sensitivity, specificity, precision, and linearity of the WRAIR qRT-PCR assay makes it well suited for detection and monitoring of HIV-2 RNA levels in plasma of infected individuals. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-02-28). Identificativi: PMID 32109949 · PMCID PMC7048284 · DOI 10.1371/journal.pone.0229424. Pagina: https://europepmc.org/article/MED/32109949 — https://doi.org/10.1371/journal.pone.0229424. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T09:32:24.289Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.